Welcome to the ValueWiki NOVARTIS AG ADS (NVS) article! Register for free or click the "edit" link to contribute!    

NOVARTIS AG ADS (NVS)

From ValueWiki

(Redirected from NVS)
Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about NOVARTIS AG ADS? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max



Funds w/ NVS: 375
Rank: 82 / 351



Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

12/01/08 4:12 pm UPDATE - Data supports Novartis malaria drug -US FDA staff (at Reuters)
12/01/08 11:12 am FDA: Novartis malaria pill shows superior results (AP)
12/01/08 9:12 am Overseas Clinical Trials Are Under the Microscope (at The Wall Street Journal Online)
12/01/08 12:12 am [$$] Scrutiny Grows of Drug Trials Abroad (at The Wall Street Journal Online)
11/28/08 9:11 pm [$$] EU Blasts Drug Titans' Tactics (at The Wall Street Journal Online)
11/28/08 10:11 am Will Patients Reject This Injection? (at Motley Fool)
11/28/08 10:11 am A Giving Strategy for Penny Pinchers (at Motley Fool)
11/28/08 6:11 am [$$] Biotech Mailbag: All About Alnylam (at RealMoney by TheStreet.com)
11/26/08 1:11 pm Watson Gets Some Hand-Me-Downs (at Motley Fool)
11/26/08 10:11 am 5-Star Stocks Poised to Pop: Novartis (at Motley Fool)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

NOVARTIS AG ADS Snapshot
NOVARTIS AG ADS Leadership
NOVARTIS AG ADS Fundamentals
NOVARTIS AG ADS Technical Analysis
NOVARTIS AG ADS Message Boards

Options

Notes

  1. This is a sample reference.
Personal tools